ProFound Therapeutics
PrivateLast Round
Corporate Funding
Jun 26, 2025
Total Funding Raised
$75M
Company Overview
ProFound Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series A round in May 2022.
ProFound Therapeutics is a biotechnology company that utilizes its proprietary ProFoundry™ Platform to systematically discover and validate novel proteins within the expanded human proteome for the development of first-in-class medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProFound Therapeutics Comparables
Compare ProFound Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quotient Therapeutics | 88% | |
| Protai | 83% | |
| Vesalius Therapeutics | 82% |
For institutional investors. Book with your work email.
ProFound Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 26, 2025 | ||||
| Series A | May 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ProFound Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notley | Series A |
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
$25M raised in corporate funding.
- Jun 26, 2025
Four-year deal to discover and develop novel therapeutics for cardiovascular disease.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingAug 27, 2026
On Aug 27th '26, ProFound receives an initial $20M investment as part of a Gates Foundation commitment of up to $35M in Massachusetts to search for biomarkers, protein drugs, and drug targets linked to preeclampsia and eclampsia.
- receives_financingAug 27, 2026
ProFound received financing of $35M in investment on Aug 27th '26.
- partners_withAug 26, 2026
On Aug 26th '26, ProFound partners with Bill & Melinda Gates Foundation in a pact worth up to $35 million to discover new drug targets for preeclampsia.
For institutional investors. Book with your work email.
ProFound Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ProFound Therapeutics's valuation, stock price, and market status.
Is ProFound Therapeutics a public or private company?
ProFound Therapeutics is a private company.
What is the current stock price of ProFound Therapeutics?
ProFound Therapeutics is a private company, so its shares have no public market price. Caplight tracks ProFound Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ProFound Therapeutics worth (valuation)?
Valuation information for ProFound Therapeutics is not publicly available.
Can I buy ProFound Therapeutics stock?
ProFound Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ProFound Therapeutics's last funding round?
ProFound Therapeutics's most recent funding round was Corporate Funding on June 26, 2025.
Who are the main investors in ProFound Therapeutics?
Key investors in ProFound Therapeutics include Flagship Pioneering.
Will ProFound Therapeutics IPO soon?
No public IPO plans have been announced for ProFound Therapeutics.
How can I track ProFound Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ProFound Therapeutics's shares on secondary markets.